TWST compared with VCYT: revenue, margins and what each company keeps, and the suppliers and customers both name

TWSTTwist Bioscience Corp

Mkt capRevenueRevenue

VCYTVeracyte, Inc.

Mkt capRevenueRevenue

Compare

TWSTTwist Bioscience Corp

VCYTVeracyte, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TWST 15

GRALGrailcustomer

WGSGeneDxcustomer

DNAGinkgo Bioworkscustomer

IBIOiBiocustomer

11 more · TWST chain ›

Shared 0

No shared counterparties.

Only VCYT 9

UNHUnitedHealthcarecustomer

BRKRNanoString (now Bruker Spatial Biology as a result of Bruker Corporation's asset acquisition of NanoString)supplier

—Silicon Valley Bankunlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Medicare

unlistedcustomer

5 more · VCYT chain ›

TWSTTwist Bioscience Corp

153.04▼−11.77%· post 152.02

Mkt cap$9.6BRevenue$118MQ3 FY26Revenue$377MFY25

VCYTVeracyte, Inc.

50.01▼−4.14%· post 49.60

ClosedOct 30 '26

Mkt cap$4.0BRevenue$150MQ2 FY26Revenue$517MFY25

Compare

ClosedOct 30 '26

TWSTTwist Bioscience Corp

VCYTVeracyte, Inc.

153.04▼−11.77%post 152.02

Price

50.01▼−4.14%post 49.60

$9.6B

Mkt cap

$4.0B

Q3 FY26$118M

Revenue

$150MQ2 FY26

FY25$377M

Revenue

$517MFY25

TWST153.04▼−11.77%vsVCYT50.01▼−4.14%ClosedOct 30 '26